Agios Pharmaceuticals (AGIO)
(Delayed Data from NSDQ)
$45.50 USD
+1.36 (3.08%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $45.48 -0.02 (-0.04%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
10/31/2024
Time: BMO |
9/2024 | $0.05 | 0.00% |
Earnings Summary
For their last quarter, Agios Pharmaceuticals (AGIO) reported earnings of -$1.69 per share, missing the Zacks Consensus Estimate of -$1.58 per share. This reflects a negative earnings surprise of 6.96%. Look out for AGIO's next earnings release on October 31, 2024. For the next earning release, we expect the company to report earnings of $0.05 per share, reflecting a year-over-year increase of 103.05%.
Earnings History
Price & Consensus
Zacks News for AGIO
FDA Grants Orphan Drug Tag to AGIO's Tebapivat for Rare Cancer
AGIO: What are Zacks experts saying now?
Zacks Private Portfolio Services